Validation and clinical performance of a single test, DNA based endometrial cancer molecular classif...
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier
About this item
Full title
Author / Creator
Jamieson, Amy , Grube, Marcel , Kommoss, Felix , Lum, Amy , Leung, Samuel , Chiu, Derek , Henderson, Gabriel , Heitz, Florian , Heublein, Sabine , Zeimet, A G , Hasenburg, Annette , Diebold, Joachim , Walter, Christina , Staebler, Annette , Reynolds, Jerian , Lapuk, Anna , McConechy, Melissa K , Huntsman, David G , Gilks, Blake , Kommoss, Stefan and McAlpine, Jessica N
Publisher
United States: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
ObjectivesWe have previously shown that DNA based, single test molecular classification by next generation sequencing (NGS) (Proactive Molecular risk classifier for Endometrial cancer (ProMisE) NGS) is highly concordant with the original ProMisE classifier and maintains prognostic value in endometrial cancer. Our aim was to validate ProMisE NGS in...
Alternative Titles
Full title
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier
Authors, Artists and Contributors
Author / Creator
Grube, Marcel
Kommoss, Felix
Lum, Amy
Leung, Samuel
Chiu, Derek
Henderson, Gabriel
Heitz, Florian
Heublein, Sabine
Zeimet, A G
Hasenburg, Annette
Diebold, Joachim
Walter, Christina
Staebler, Annette
Reynolds, Jerian
Lapuk, Anna
McConechy, Melissa K
Huntsman, David G
Gilks, Blake
Kommoss, Stefan
McAlpine, Jessica N
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3125388594
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3125388594
Other Identifiers
ISSN
1048-891X,1525-1438
E-ISSN
1525-1438
DOI
10.1136/ijgc-2024-005916
